For the experimental model we have been using, we could however exclude tumor cells as the source of S100A8/A9, by analysis of cell lysates and tissue culture supernatants, and by FACS of harvested tumor tissue, showing virtually all S100A9+ cells in the 4T1.2 model, to be CD11b+ 15. This evidence concerns the gene S100A9 and neoplasm.